Advanced Biomed Inc. (ADVB) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Advanced Biomed Inc. (ADVB:NASDAQ), powered by AI.
- Current Price
- $6.69
- Market Cap
- 137M
- Sector
- Healthcare
What is the Advanced Biomed Inc. stock price forecast?
Advanced Biomed Inc. is currently trading at $6.69. View real-time AI analysis on Alpha Lenz.
What is Advanced Biomed Inc. insider trading activity?
View the latest insider trading data for Advanced Biomed Inc. on Alpha Lenz.
What is Advanced Biomed Inc.'s P/E ratio?
View Advanced Biomed Inc.'s valuation metrics on Alpha Lenz.
Advanced Biomed Inc.
NASDAQ · ADVBCompany Overview
Advanced Biomed Inc. is a biotechnology company primarily focused on the development and commercialization of innovative therapeutic solutions. The company specializes in creating advanced treatments for various chronic and severe diseases, significantly impacting the healthcare and pharmaceutical sectors. Advanced Biomed Inc. employs cutting-edge biotechnological processes to discover and develop treatments aimed at improving patient care and outcomes. Its commitment to research and development allows the company to explore new frontiers in medical science, fostering innovation in drug discovery and delivery. The company's products and potential therapies play a vital role in the global effort to address unmet medical needs and provide effective solutions in disease management.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
Frequently Asked Questions
Advanced Biomed Inc. (ticker: ADVB) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 31 employees. Market cap is $137M.
The current price is $6.69 with a P/E ratio of -x and P/B of -x.